Synthesis and pharmacological evaluation of 1-(1-((substituted)methyl)-5- methyl-2-oxoindolin-3-ylidene)-4-(substituted pyridin-2-yl)thiosemicarbazide

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 7, 2008, Pages 1461-1464

  Muthukumar, Vijey Aanandhi ^a   George, Shiny ^a   Vaidhyalingam, Venkatachalam ^b  

^a VELS INSTITUTE OF SCIENCE   (India)

^b MADRAS MEDICAL COLLEGE   (India)

Author keywords

Analgesic; Anti inflammatory; Isatin; Mannich base; Schiff base

Indexed keywords

1 [1 [[ETHYL(PROPYL)AMINO]METHYL] 5 METHYL 2 OXOINDOLIN 3 YLIDENE] 4 (4 METHYLPYRIDIN 2 YL)THIOSEMICARBAZIDE; 1 [1 [[ETHYL(PROPYL)AMINO]METHYL] 5 METHYL 2 OXOINDOLIN 3 YLIDENE] 4 (6 METHYLPYRIDIN 2 YL)THIOSEMICARBAZIDE; ACETIC ACID; AMINE; CARRAGEENAN; DICLOFENAC; FORMALDEHYDE; INDOLE DERIVATIVE; ISATIN DERIVATIVE; MANNICH BASE; PYRIDINE DERIVATIVE; THIOSEMICARBAZIDE DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; PAW EDEMA; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CHEMISTRY, PHYSICAL; EDEMA; FEMALE; FORMALDEHYDE; INDICATORS AND REAGENTS; INDOLES; ISATIN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANNICH BASES; MASS SPECTROMETRY; PAIN MEASUREMENT; RATS; SPECTROPHOTOMETRY, INFRARED; THIOSEMICARBAZONES;

EID: 46449096048     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1461     Document Type: Article

References (22)

1. Medvedev A. E., Clow A., Sandler M., Glover V., Biochem. Pharmacol., 52, 385-391 (1996).
2. Watkins P., Clow A., Glover V., Halket J., Przyborowska A., Sandler M., Neurochem. Int., 17, 321-323 (1990).
3. Glover V., Bhattacharya S. K., Charkrabarti A., Sandler M., Stress Med., 14, 225-229 (1998).
4. Medvedev A., Bussygyna O., Pyatakova N., Glover V., Severina I., Biochem. Pharmacol., 63, 763-766 (2002).
5. Glover V., Medvedev A., Sandler M., Life Sci., 57, 2073-2079 (1995).
6. Pandeya S. N., Sriram D., Acta Pharm. Turc., 40, 33 (1998).
7. Sarangapani M., Reddy V. M., Indian J. Pharm. Sci., 56, 174-177 (1994).
8. Varma R. S., Nobles W. L., J. Pharm. Sci., 64, 881-882 (1975).
9. Pandeya S. N., Sriram D., Nath G., De Clercq E., Indian J. Pharm. Sci., 61, 358-361 (1999).
10. Pandeya S. N., Sriram D., Nath G., De Clercq E., Sci. Pharm., 67, 103-111 (1999).
11. Pandeya S. N., Sriram D., Nath G., De Clercq E., Pharm. Acta Helv., 74, 11-17 (1999).
12. Varma R. S., Nobles W. L., J. Med. Chem., 10, 972-974 (1967).
13. Singh S. P., Shukla S. K., Awasthi L. P., Curr. Sci., 52, 766-769 (1983).
14. Logan J. C., Fox M. P., Morgan J. M., Makohon A. M., Pfau C. J., J. Gen. Virol., 28, 271-283 (1975).
15. Pandeya S. N., Yogeeswari P., Sriram D., De Clercq E., Pannecouque C., Witvrouw M., Chemotherapy, 45, 192-196 (1999).
16. Pandeya S. N., Sriram D., Nath G., De Clercq E., Eur. J. Med. Chem., 35, 249-255 (2000).
17. Pandeya S. N., Sriram D., Nath G., De Clercq E., Arzneim.-Forsch./Drug Res., 50, 55-59 (2000).
18. Imam S. A., Varma R. S., Experientia, 31, 1287-1288 (1975).
19. Varma R. S., Khan I. A., Polish J. Pharmacol. Pharm., 29, 549-594 (1977).
20. David C., Marie T., Roussel G., U.S. Pat. 5,498,716 (1996) [Chem. Abstr., 124, 343271 (1996)].
21. Sarangapani M., Reddy V. M., Indian J. Pharm. Sci., 59, 105 (1997).
22. Sridhar S. K., Atmakuru Ramesh, Indian Drugs, 38, 174-180 (2001).